Alok Chandra Bharti

Employment

• University of Delhi (North Campus) Professor and Laboratory Chief
  2016 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (99)

• Phytochemicals Showing Antiangiogenic Effect in Pre-clinical Models and their Potential as an Alternative to Existing Therapeutics
  Current Topics in Medicinal Chemistry 2024 DOI: 10.2174/0115680266264349231016094456
  +Save
• Chick chorioallantoic membrane: a valuable 3D in vivo model for screening nanoformulations for tumor antiangiogenic therapeutics
  International Journal of Developmental Biology 2023 DOI: 10.1387/ijdb.230198pb
  +Save
• In vivo antiangiogenic effect of nimbolide, trans-chalcone and piperine for use against glioblastoma
  BMC Cancer 2023 DOI: 10.1186/s12885-023-11625-4
  +Save
• Physical interaction between STAT3 and AP1 in cervical carcinogenesis: Implications in HPV transcription control
  Biochimica et Biophysica Acta - Molecular Basis of Disease 2023 DOI: 10.1016/j.bbadis.2023.166817
  +Save
• Quantitative assessment of antioxidant potential of selected homeopathic preparations in clinical practice
  Drug Metabolism and Personalized Therapy 2023 DOI: 10.1515/dmpt-2022-0169
  +Save
• Role of angiotensin in different malignancies
  Angiotensin: From the Kidney to Coronavirus 2023 DOI: 10.1016/B978-0-323-99618-1.00019-2
  +Save
• Investigation of molecular mechanisms underlying JAK/STAT signaling pathway in HPV-induced cervical carcinogenesis using ‘omics’ approach
  Medical Oncology 2022 DOI: 10.1007/s12032-022-01854-1
  +Save
• Detection of human papillomavirus infection in oral cancers reported at dental facility: assessing the utility of FFPE tissues
  Medical Oncology 2022 DOI: 10.1007/s12032-021-01608-5
  +Save
• Evaluation of Therapeutic Potential of Selected Plant-Derived Homeopathic Medicines for their Action against Cervical Cancer
  Homeopathy 2022 DOI: 10.1055/s-0042-1756436
  +Save
• RNA splicing: a dual-edged sword for hepatocellular carcinoma
  Medical Oncology 2022 DOI: 10.1007/s12032-022-01726-8
  +Save